echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > AP&T: Risk of schizophrenia and new-onset inflammatory bowel disease

    AP&T: Risk of schizophrenia and new-onset inflammatory bowel disease

    • Last Update: 2022-05-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Risk of schizophrenia and new-onset inflammatory bowel disease Schizophrenia is a common serious mental illness, and its patients account for about 50% of the total number of hospitalized mental patients in China, and the global lifetime prevalence rate is about 0.


    Risk of schizophrenia and new-onset inflammatory bowel disease Schizophrenia is a common serious mental illness, and its patients account for about 50% of the total number of hospitalized mental patients in China, and the global lifetime prevalence rate is about 0.


    diagnosis

    Among 116,164 patients with schizophrenia and 464,656 matched controls, patients had a significantly higher overall incidence of IBD (1.


    Thus, this population-based cohort study demonstrated a significant association between schizophrenia and subsequent development of IBD


    Thus, this population-based cohort study demonstrated a significant association between schizophrenia and subsequent development of IBD


    Original source:

    Kuan-Yi Sung.


    Kuan-Yi Sung.
    Et al.
    Schizophrenia and risk of new-onset inflammatory bowel disease: a nationwide longitudinal study .
    Alimentary Pharmacology & Therapeutics.
    2022.
    Schizophrenia and risk of new-onset inflammatory bowel disease: a nationwide longitudinal study Leave a

    message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.